MetLife Investment Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

MetLife Investment Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,517	Closed	-$10.8K	–	2785
2021 Q4	$10.8K	Sell	8,517 -52,028	-86%	-$93K	﹤0.01%	2493
2021 Q3	$132K	Buy	60,545 +29,725	+96%	+$81.2K	﹤0.01%	2314
2021 Q2	$116K	Sell	30,820 -29,620	-49%	-$103K	﹤0.01%	2394
2021 Q1	$197K	Sell	60,440 -1,965	-3%	-$7.04K	﹤0.01%	2058
2020 Q4	$213K	Sell	62,405 -1,859	-3%	-$7.65K	﹤0.01%	1951
2020 Q3	$262K	Buy	64,264 +12,330	+24%	+$46.9K	﹤0.01%	1693
2020 Q2	$176K	Hold	51,934	–	–	﹤0.01%	1979
2020 Q1	$121K	Hold	51,934	–	–	﹤0.01%	1977
2019 Q4	$189K	Hold	51,934	–	–	﹤0.01%	2008
2019 Q3	$431K	Hold	51,934	–	–	﹤0.01%	1499
2019 Q2	$447K	Buy	51,934 +6,099	+13%	+$54.6K	﹤0.01%	1546
2019 Q1	$490K	Hold	45,835	–	–	0.01%	1464
2018 Q4	$401K	Hold	45,835	–	–	﹤0.01%	1505
2018 Q3	$770K	Hold	45,835	–	–	0.01%	1265
2018 Q2	$961K	Buy	45,835 +5,188	+13%	+$96.1K	0.01%	1033
2018 Q1	$654K	Hold	40,647	–	–	0.01%	1217
2017 Q4	$770K	Buy	+40,647	New	+$736K	0.01%	1152

Other funds holding SPPI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

MetLife Investment Management's SPPI Position: Q1 2022 in Review

MetLife Investment Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 8,517 shares — an estimated $10.8K sold.

MetLife Investment Management first reported a position in SPPI in Q4 2017 and held it in 17 quarters. The position peaked at $961K in Q2 2018. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

MetLife Investment Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
MetLife Investment Management sold 8,517 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $10.8K.
MetLife Investment Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and held it in 17 quarters.
MetLife Investment Management's Spectrum Pharmaceuticals Inc position peaked at $961K in Q2 2018.
101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.